Philippe Merle

Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial

Masatoshi Kudo, Osamu Yokosuka, Gianluca Masi, 2017, The Lancet.

Comparison of no-touch multi-bipolar vs. monopolar radiofrequency ablation for small HCC.

Christophe Aubé, Hervé Trillaud, Olivier Seror, 2017, Journal of hepatology.

Gene signatures in hepatocellular carcinoma (HCC).

O. Andrisani, P. Merle, Philippe Merle, 2011, Seminars in cancer biology.

Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma

Gisela Schwab, Tim Meyer, Stephen Lam Chan, 2018, The New England journal of medicine.